Asset Management Company
Valcreate Lifesciences
Valcreate Lifesciences is a SEBI-registered asset manager. PMS Sahi Hai tracks 1 of its 1 PMS strategy, scored on the same basis as every other house.
1 strategy— trackedAvg Nyra 7.7
AUM tracked
—
Strategies
1
1 PMS
Avg Nyra Score
7.7
Best 3Y CAGR
18.3%
Valcreate Lifesciences and Specialty Opportunities
Fund managers
About the house
How Valcreate Lifesciences invests
Across the strategy PMS Sahi Hai tracks, Valcreate Lifesciences runs thematic mandates in a blend style, with — under watch and a track record stretching back 3 years.
Its strongest three-year run on our shelf is 18.3% CAGR on Valcreate Lifesciences and Specialty Opportunities, net of fees. Every strategy here is graded on the same comparative basis (including returns, risk, manager tenure, fees, concentration, transparency and AUM fit), so Valcreate Lifesciences can be read side by side against any other house on the platform, sales deck excluded.
Categories
Thematic
Styles
Blend
Minimums
₹50 L (PMS)